Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites

  • participants needed
  • sponsor
    Jerome Canady, M.D.
Updated on 13 May 2021
platelet count
white blood cell count
absolute neutrophil count
international normalized ratio
serum bilirubin level
neutrophil count
liver metastasis
solid tumor


The study designed is to evaluate the safety of Canady Helios Cold Plasma Scalpel (CHCPS) in patients with solid tumors with carcinomatosis scheduled to undergo surgical resection for cytoreduction. Patients with stage 4 resectable tumors as decided by a multidisciplinary disease management team may be included if the metastatic disease is non-synchronous (e.g. recurrent colorectal carcinoma with hepatic metastasis amenable for surgical resection).. Plasma is an ionized gas typically generated in high-temperature laboratory conditions. Plasma coagulators are currently used routinely as surgical tools with multiple applications that create temperatures between 37 C to 43C and cause thermal injury. Earlier studies demonstrated the non-aggressive nature of cold plasma. As evidence accumulates, it is becoming clear that low-temperature cold plasma has an increasing role in biomedical applications.

Condition Metastatic Breast Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Metastatic Gastric Cancer, Stage IV Renal Cell Cancer, Recurrent Malignant Solid Neoplasm, Stage IV Breast Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer, Stage IV Ovarian Cancer, Stage IV Pancreatic Cancer, Stage IV Fallopian Tube Cancer, Stage IV Colorectal Cancer, Stage IV Gastric Cancer, Stage IV Ovarian Epithelial Cancer, Metastatic Colon Cancer, Stage IV Lung Cancer, Stage IV Liver Cancer, Metastatic Bladder Cancer, Stage IV Small Intestinal Cancer, Metastatic Bladder Carcinoma, To Evaluate the Safety of Canady Helios Cold Plasma Scalpel in Patients With Solid Tumors With Carcinomatosis Undergoing Surgical Resection for Cytoreduction, Stage IV Non-small Cell Lung Cancer, metastatic stomach cancer, stage iv kidney cancer, Stage IV Non-small Cell Lung Cancer
Treatment Canady Helios Cold Plasma Scalpel
Clinical Study IdentifierNCT04267575
SponsorJerome Canady, M.D.
Last Modified on13 May 2021

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note